Simon Zhornitsky. Associate Research Scientist. Edit this profile Contact Info. Simon Zhornitsky. Email [email protected] Close. image. Close. Depression in multiple sclerosis: a long-term longitudinal study. MW Koch, S Patten, S Berzins, S Zhornitsky, J Greenfield, W Wall, Multiple Sclerosis Journal . Simon Zhornitsky of The University of Calgary, Calgary (HBI) with expertise in: Clinical Pharmacology, Clinical Trials and Clinical Immunology. Read
However, data … More. Substance use disorders SUDs are common in patients with schizophrenia and this comorbidity is associated with a poorer prognosis, relative to non-abusing patients. One hypothesis that has been … More. Multiple sclerosis MS is more common among women than men. MS often goes into remission during pregnancy, when prolactin PRL levels are known to be high. In an animal model of demyelination, PRL … More.
Revue Canadienne De Psychiatrie. Long-term persistence with injectable therapy in relapsing-remitting multiple sclerosis: Depression in multiple sclerosis: Multiple Sclerosis Houndmills, Basingstoke, England.
A randomized controlled trial with a Canadian electronic pill dispenser used to measure and improve medication adherence in patients with schizophrenia. Quetiapine fumarate for the treatment of multiple sclerosis: Predictors of community functioning in schizophrenia and substance use disorder patients.
Community Mental Health Journal. Cannabidiol in humans-the quest for therapeutic targets. Sensation-seeking, social anhedonia, and impulsivity in substance use disorder patients with and without schizophrenia and in non-abusing schizophrenia patients. Comparing tolerability of olanzapine in schizophrenia and affective disorders: The system can't perform the operation now. The following articles are merged in Scholar. Their combined citations are counted only for the first article.
This "Cited by" count includes citations to the following articles in Scholar. New articles by this author. New citations to this author. New articles related to this author's research.
Email address for updates. My profile My library Metrics Alerts. Yale School of Medicine. International Clinical Psychopharmacology 26 4 , , Journal of clinical psychopharmacology 30 4 , ,
View Simon Zhornitsky's profile on LinkedIn, the world's largest professional community. Simon's education is listed on their profile. See the complete profile on. Simon Zhornitsky. University of Calgary. Calgary, Canada. View All. mini profile avatar Simon Zhornitsky. Overview · Bio · Network8 · Publications14 · Editorial. View Simon Zhornitsky's business profile as Associate Research Scientist at Yale University and see work history, affiliations and more.